top of page

No-Exam Term Life Insurance with a Pacemaker: Why Instant Approval Is Often Difficult

Written by: Jeff Schmidt | Licensed Insurance Broker | CarePro Insurance Content reviewed for accuracy. Not legal, tax, or financial advice.

A pacemaker usually signals an underlying rhythm or cardiac issue. Accelerated/no-exam programs often filter for that, while traditional underwriting looks at the reason for implantation and stability since.

  • Instant online pricing

  • No phone calls required

  • No pressure from agents

The Device Isn't the Whole Story

Why the device was implanted (diagnosis and history)

Time since implantation and any recent events

Cardiology follow-up, testing, and current stability

If you have a pacemaker, ICD, or other implanted cardiac device, you've probably noticed that many 'instant' quote paths don't accommodate it -- typically because accelerated programs are designed for fast screening using limited data, and implanted cardiac devices signal a cardiac history that requires deeper evaluation than a quick filter can complete. Understanding what type of device you have matters to that evaluation, because the three main categories serve distinct clinical purposes: a permanent pacemaker treats bradycardia -- a rhythm that is too slow or intermittently absent -- by delivering electrical pacing pulses. An ICD (implantable cardioverter-defibrillator) monitors for life-threatening rapid rhythms and delivers therapy to terminate them. A CRT (cardiac resynchronization therapy) device addresses heart failure with electrical dyssynchrony and may also incorporate ICD functionality in the same unit.

Traditional underwriting is usually where the real conversation happens, and one of the most important distinctions underwriters draw for ICD cases is between primary and secondary prevention. A primary prevention ICD is implanted prophylactically -- before any documented life-threatening arrhythmia -- because the patient's clinical profile indicates high future risk based on factors like reduced ejection fraction or a known inherited channelopathy. A secondary prevention ICD is implanted after a cardiac arrest or a sustained episode of ventricular tachycardia or ventricular fibrillation has already occurred. Secondary prevention cases typically involve more underwriting scrutiny because the life-threatening arrhythmia has already been documented and the question becomes how the underlying condition has been managed since that event rather than whether the event has occurred.

Expect the underwriting process to include questions about follow-up with cardiology, any recent symptoms or hospitalizations, and recent device interrogation data. Device interrogation reports -- generated at each cardiology follow-up visit -- show the device's therapy delivery history: whether an ICD has fired, how often, and what rhythm triggered each event. Underwriters may specifically request these reports because they provide direct objective evidence of how the device and the underlying arrhythmia have behaved since implantation. A device that has never delivered therapy and a device that has fired multiple times represent clinically different situations, and the specific rhythm that triggered any therapy is as important to the underwriting assessment as the fact that the device fired.

It's also important to separate an 'instant decline' from a conclusion that you can't be insured. A decline in an accelerated track typically means the carrier cannot make a decision within the quick-filter framework -- not that the carrier will refuse coverage through traditional underwriting with a full medical review. The underlying cardiac diagnosis is usually more important to the final decision than the device itself: structural heart disease, cardiomyopathy, and inherited channelopathies like long QT syndrome or hypertrophic cardiomyopathy each carry distinct risk profiles that actuarial tables address specifically. Underwriters evaluating those diagnoses are working from disease-specific data rather than a blanket device classification.

If you want to avoid delays in the traditional underwriting process, have a clean summary ready before you apply: device type (pacemaker, ICD, or CRT), implant date, the underlying diagnosis that led to implantation, most recent cardiology visit date, and any device interrogation findings you're aware of. Clear documentation helps the carrier make a decision without guesswork, reduces back-and-forth during the records review phase, and gives you a clearer picture of which carriers have well-developed cardiac underwriting programs before you invest time in an application that an accelerated filter will simply route to postponement. Applicants who arrive at traditional underwriting with organized cardiology records and recent interrogation data typically move through the review faster than those whose records need to be reconstructed through attending physician statement requests.

For the broader term life guide and underwriting paths (including when no-exam isn't available), see: https://www.careproinsurance.com/instant-term-life-insurance

For education only. Not intended as legal, medical, or tax guidance. Quotes are estimates and final eligibility/pricing depend on underwriting and the issued policy terms.

Frequently Asked Questions

Can I get no-exam term life insurance with a pacemaker?

Sometimes, but many instant/accelerated programs don't accept implanted devices. Traditional underwriting may still offer options depending on the underlying condition and stability.

Why do instant programs often decline pacemakers or ICDs?

Accelerated programs use strict filters to keep decisions fast. Implanted devices usually signal a cardiac history that requires deeper review. Exact rules vary by program.

Does the reason for the pacemaker matter?

Yes. Underwriting typically evaluates the underlying rhythm disorder or diagnosis, plus stability since implantation and any recent events.

Will I need a medical exam with a pacemaker?

Not always, but more detailed underwriting and records review are common. Requirements depend on coverage amount, timing, and your cardiology history.

What information should I have ready before applying?

Helpful details include implant date, the reason for implantation, recent cardiology visit notes, and recent testing summaries. Exact requirements vary by carrier.

What is the difference between a primary prevention ICD and a secondary prevention ICD from an underwriting perspective?

A primary prevention ICD is implanted before any documented life-threatening arrhythmia -- placed because the clinical risk profile indicates high probability of a future event. A secondary prevention ICD is implanted after a cardiac arrest or sustained ventricular tachycardia or fibrillation has already occurred. Secondary prevention cases involve more underwriting scrutiny because the life-threatening arrhythmia has been documented and the underlying risk has already manifested.

What are device interrogation reports, and why might an underwriter ask for them?

Device interrogation reports are generated during cardiology follow-up visits and document the device's function history -- whether an ICD delivered therapy, how many times, and what rhythm triggered each event. Underwriters request them because they provide objective evidence of how the device and the underlying arrhythmia have behaved since implantation, which is more informative than the implant date alone.

Does the underlying cardiac diagnosis matter more than the type of device for underwriting purposes?

Generally, yes. The device is a treatment for an underlying condition, and underwriters evaluate the condition itself using actuarial tables specific to each diagnosis. Structural heart disease, cardiomyopathy, and inherited channelopathies each carry distinct risk profiles that shape the underwriting decision more than the device category alone. The device type and therapy history are important supporting context, but the underlying diagnosis typically drives the rate class determination.

Get Covered With The Right Plan

Explain why implanted devices trigger accelerated-program declines and what underwriters need to evaluate the underlying cardiac history in traditional review.

Compare term life options

bottom of page